The content creator, 26, has been participating in a clinical trial to treat her stage 4 cholangiocarcinoma, or bile duct ...

The influencer, 26, is participating in a new clinical trial for her rare bile duct cancer ...

Compass Therapeutics recently reported that its Phase 2/3 COMPANION-002 trial in previously treated advanced biliary tract cancer met the primary endpoint, with tovecimig plus paclitaxel achieving ...

A trial drug, which is prescribed when surgery is no longer an option, gave Huw precious time to see Idris turn one.

Compass Therapeutics said its cancer treatment improved progression-free survival in a recent trial, but didn't meet its secondary endpoint in overall survival. Shares fell 23% to $3.85 in premarket ...

At Huntsman Cancer Institute, our experts deliver specialized, multidisciplinary care for bile duct cancer (cholangiocarcinoma). You are supported by a team of specialists including hepatobiliary ...

Compass Therapeutics says a treatment evaluating its cancer treatment didn’t meet the secondary endpoint for an unexpected ...

A global comparative study on real-world clinical and genomic differences in advanced biliary tract cancer. Extra-hepatic (ehCCA) and intra-hepatic cholangiocarcinomas (iCCA): A genomic landscape ...

A new targeted treatment for a rare and aggressive form of bile duct cancer has been recommended by NICE for routine use on the NHS in England, giving people more time with better quality of life.

Bile duct cancer, or cholangiocarcinoma, is a serious concern due to its rapid progression and often mild, easily mistaken ...

About 8,000 people are diagnosed with bile duct cancer each year. But the actual number of cases is likely to be higher, because these cancers can be hard to diagnose, and some might be misclassified ...

Bile duct and gallbladder cancers are uncommon, with an estimated 12,130 new cases diagnosed this year according to the American Cancer Society. These cancers develop in organs deep inside the body, ...